Abstract:NGS-based genetic testing in the diagnosis of rare diseases holds great promise to serve as a first-tier genetic testing tool in the near future.Advancement of NGS technologies provides many options for diagnosing rare disorders associated with different types of genetic variants. Factors must be balanced in a ‘fit-for-purpose’ implementation.The accuracy and reproducibility of NGS should be evaluated in a clinical setting to deliver reliable genetic testing results in different clinical stages of rare diseases.Artificial intelligence (AI) will play a central role in integrating diverse diagnosis information toward an enhanced diagnosis power for rare diseases. Next-generation sequencing (NGS) technologies have changed the landscape of genetic testing in rare diseases. However, the rapid evolution of NGS technologies has outpaced its clinical adoption. Here, we re-evaluate the critical steps in the clinical application of NGS-based genetic testing from an informatics perspective. We suggest a ‘fit-for-purpose’ triage of current NGS technologies. We also point out potential shortcomings in the clinical management of genetic variants and offer ideas for potential improvement. We specifically emphasize the importance of ensuring the accuracy and reproducibility of NGS-based genetic testing in the context of rare disease diagnosis. We highlight the role of artificial intelligence (AI) in enhancing understanding and prioritization of variance in the clinical setting and propose deep learning frameworks for further investigation. Next-generation sequencing (NGS) technologies have changed the landscape of genetic testing in rare diseases. However, the rapid evolution of NGS technologies has outpaced its clinical adoption. Here, we re-evaluate the critical steps in the clinical application of NGS-based genetic testing from an informatics perspective. We suggest a ‘fit-for-purpose’ triage of current NGS technologies. We also point out potential shortcomings in the clinical management of genetic variants and offer ideas for potential improvement. We specifically emphasize the importance of ensuring the accuracy and reproducibility of NGS-based genetic testing in the context of rare disease diagnosis. We highlight the role of artificial intelligence (AI) in enhancing understanding and prioritization of variance in the clinical setting and propose deep learning frameworks for further investigation.

Challenges in the application of NGS in the clinical laboratory

Next-generation sequencing in the clinic: Promises and challenges

Application of Next Generation Sequencing in Laboratory Medicine

Next-generation sequencing and its applications in molecular diagnostics

The status quo and future prospects of the next generation sequencing technologies in clinical diagnostics

Next Generation Sequencing Technology in the Clinic and Its Challenges

HLA genotyping in the clinical laboratory: comparison of next-generation sequencing methods

Clinical Next Generation Sequencing for Precision Medicine in Cancer

High-Throughput Metagenomics for Identification of Pathogens in the Clinical Settings

Development of high-throughput sequencing and its application and prospect in clinical molecular diagnosis

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use

Current Status and Recent Advances of Next Generation Sequencing Techniques in Immunological Repertoire

Clinical diagnostic value of targeted next‑generation sequencing for infectious diseases (Review)

Next Generation Sequencing: Latent Applications in Clinical Diagnostics with the advent of Bioinformatic Frameworks

Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)

From DNA to Data: Transcending Beyond the Double Helix and Demystifying the Genetic Alchemy of Life Through NGS to Empower Precision Medicine

Privacy and ethical challenges in next-generation sequencing

Application of next-generation sequencing to identify different pathogens

Clinical applications of metagenomics next-generation sequencing in infectious diseases

The application of long-read sequencing in clinical settings

Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?